Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
This grant opportunity supports the early development of new small-molecule and biologic drugs aimed at preventing, slowing, or treating Alzheimer's disease. Funding is available for activities including medicinal chemistry, pharmacokinetics, toxicology studies, animal model efficacy, biomarker development, drug formulation, GMP chemical synthesis, IND-enabling studies, and Phase I clinical tr…
The goal of this Notice of Funding Opportunity (NOFO) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer's disease (AD), slow its progression, or treat its cognitive and beh…
Funding Source
Awards & funding
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers